Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor

Francesco Danilo Tiziano, Daniela Gasparotto, Sabrina Rossi, Domenico Campagna, Paola Scavina, Alessandra Marzotto, Luisa Toffolatti, Carlo E. Vitelli, Mostafa Amini, Angelo P. Dei Tos, Roberta Maestro

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

no abstract available
Original languageEnglish
Pages (from-to)e99-e103
JournalJournal of Clinical Oncology
Volume34
DOIs
Publication statusPublished - 2016

Keywords

  • Abdominal Wall
  • Adult
  • Antineoplastic Agents
  • Cancer Research
  • Chemotherapy, Adjuvant
  • Disease Progression
  • Drug Administration Schedule
  • Female
  • Gastrointestinal Stromal Tumors
  • Germ-Line Mutation
  • Humans
  • Imatinib Mesylate
  • Mutation
  • Oncology
  • Paraganglioma
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins c-kit
  • Receptor, Platelet-Derived Growth Factor alpha
  • Rectal Neoplasms
  • Succinate Dehydrogenase
  • Treatment Outcome

Fingerprint

Dive into the research topics of 'Imatinib-Sensitizing KIT Mutation in a Carney-Stratakis-Associated GI Stromal Tumor'. Together they form a unique fingerprint.

Cite this